Jim O’Neill, President Trump’s pick to be second-in-command at HHS, has a history of working with vaccine companies and other ...

The U.K. is starting to recognize that the country needs to change how it pays for medicines to attract more pharma investment, officials said.

A report by a New York congressman details consumer and employee grievances with UnitedHealth Group’s management of two medical groups ...

President Trump yesterday announced a baseline tariff of 10% on all imported products and higher rates on certain countries ...

The Trump administration carved out an exception for pharmaceuticals from the president's new tariff regime, at least for now ...

The court also ruled in favor of a truck driver who failed a drug test and lost his job after taking a CBD supplement for ...

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...

A paper proposing NIH reforms is circulating in academic circles and within the agency as scientists search for hints of its ...

Erythropoietin, aka EPO, is best known for its role in the Lance Armstrong cheating scandal. But EPO is also the star of ...

If we cut or limit funding for curiosity-driven research, we risk shutting down the pipeline of future innovation,” writes ...

FDA and CDC cuts will only exacerbate problems with tobacco regulation and enforcement, say public health experts ...

The suit filed Wednesday aims to restore funding and end grant cancellations, arguing they violate NIH’s science-based review ...